Leukemia Nursing Care Plans

Leukemia is a malignant proliferation of white blood cell precursors in bone marrow or lymph tissue, with accumulation in peripheral blood, marrow, and body tissues. Blood cells originate mainly in the marrow of bones like the sternum, iliac crest, and cranium. All blood cells start as immature blasts (stem cells) that mature into RBCs, platelets, and WBCs. In leukemia, immature or ineffective WBCs crowd out the developing normal cells, and as they take over you get anemia, neutropenia, and thrombocytopenia. On the floor that translates into three things that drive every shift: infection risk, bleeding risk, and the toll of chemotherapy.

Nursing Priorities

1. Minimize infection through infection control.
2. Manage the side effects of chemotherapy.
3. Manage pain.
4. Provide emotional support.
5. Provide health teaching.

Nursing Assessment

Assess for these subjective and objective findings:

• Reports of pain (bone, nerve, headaches)
• Guarding or distraction behaviors, facial grimacing, altered muscle tone
• Autonomic responses
• Fatigue or weakness
• Exertional discomfort or dyspnea
• Abnormal HR or BP response
• Requests for information, statements reflecting misconception

Contributing factors to watch:

• Inadequate secondary defenses: altered mature WBCs (low granulocyte and abnormal lymphocyte count), increased immature lymphocytes, immunosuppression, bone marrow suppression from therapy or transplant
• Inadequate primary defenses (stasis of body fluids, traumatized tissue)

Nursing Goals

• The client identifies actions to prevent or reduce infection risk.
• The client demonstrates techniques and lifestyle changes that promote a safe environment and timely healing.

Nursing Interventions and Actions

1. Infection Control and Management

Leukemia wrecks normal blood cell production, including the WBCs that fight infection, and chemotherapy suppresses the immune system further. Infection prevention is the single highest-yield thing you do for these patients.

1. Monitor temperature closely. Note the link between temperature spikes and chemotherapy. Watch for fever with tachycardia, hypotension, and subtle mental changes. Fever can accompany chemotherapy, but progressive hyperthermia points to infection, and most leukemia patients run fever unrelated to drugs or blood products. Septicemia can also occur without fever.

2. Inspect skin for tender, erythematous areas and open wounds. Cleanse with antibacterial solutions. These signal local infection. Open wounds may not produce pus because granulocytes are too few.

3. Inspect oral mucous membranes and provide good oral hygiene. Use a soft toothbrush, sponge, or swabs. The oral cavity grows organisms readily and is prone to ulceration and bleeding.

4. Auscultate breath sounds for crackles and rhonchi. Inspect secretions for increased sputum or color change. Check urine for cloudiness, foul smell, urgency, or burning. Early intervention prevents sepsis in immunosuppressed patients.

5. Monitor laboratory studies. See Laboratory and Diagnostic Procedures.

6. Place in a private room and limit visitors. Prohibit live plants and flowers. Restrict fresh fruit unless washed or peeled. Keep staff who care for infectious patients away from the leukemic patient. Bone marrow suppression, neutropenia, and chemotherapy put the patient at high risk, so you remove every avoidable source of pathogens.

7. Require strict handwashing for all staff and visitors. Prevents cross-contamination.

8. Prevent chilling. Force fluids and give a tepid sponge bath. Reduces fever, which drives fluid imbalance, discomfort, and CNS complications.

9. Encourage frequent turning and deep breathing. Prevents stasis of respiratory secretions and lowers the risk of atelectasis or pneumonia.

10. Handle the patient gently. Keep linens dry and wrinkle-free. Prevents sheet burn and skin excoriation.

11. Avoid indwelling urinary catheters and IM injections. Both create an entry point for infection.

12. Keep the skin and perianal area clean and apply mild lotion to prevent drying or cracking. Clean skin thoroughly before any invasive procedure. Intact skin is a barrier you cannot afford to lose.

13. Change IV tubing per facility policy. Use strict sterile technique and metal scalp vein needles when starting an IV. If the patient is on total parenteral nutrition, give scrupulous subclavian catheter care. Frequent chemotherapy irritates the vein and raises infection risk, so rotating the site and keeping tubing sterile protects both the line and the patient.

14. Promote perianal hygiene. Examine the perianal area at least daily during acute illness. Provide sitz baths with Betadine or Hibiclens if indicated. Avoid rectal temperatures and suppositories. A perianal abscess can drive septicemia and death in an immunocompromised patient.

15. Cluster procedures and tests to protect uninterrupted rest. Conserves energy for healing and cellular regeneration.

16. Encourage high-protein foods, fluids, and adequate fiber. Promotes healing and prevents dehydration. Constipation retains toxins and risks rectal injury.

17. Limit invasive procedures (venipuncture, injections) when possible. Any break in the skin is an entry for lethal organisms. A central venous line (tunneled catheter or implanted port) cuts the need for repeated sticks. Myelosuppression can be cumulative, especially with multidrug therapy including steroids.

18. Prepare for and assist with leukemia-specific treatments: chemotherapy, radiation, bone marrow transplant. Leukemia is usually treated with a combination of these, each with its own safety precautions for patient and staff.

19. Administer medications as indicated. See Pharmacologic Management.

20. Avoid aspirin-containing antipyretics. Aspirin can cause gastric bleeding and further drop the platelet count.

21. Provide a high-protein, high-calorie diet. Avoid raw fruit, vegetables, and uncooked meat. Good nutrition supports the immune system while cutting sources of bacterial contamination.

2. Managing Fluid Volume

These patients lose volume to vomiting, diarrhea, and bleeding, take in less from poor appetite, and need more during fever or chemotherapy. Stay ahead of dehydration and electrolyte imbalance.

1. Monitor I&O. Calculate insensible losses and fluid balance. Note low urine output despite adequate intake. Measure specific gravity and urine pH. Tumor lysis syndrome releases toxic levels of potassium, phosphorus, and uric acid when cancer cells die. Elevated phosphorus and uric acid crystallize in the renal tubules, impair filtration, and lead to renal failure.

2. Weigh daily. Gauges fluid replacement and kidney function. Intake exceeding output may signal renal insult or obstruction.

3. Monitor BP and HR. Changes reflect hypovolemia from bleeding or dehydration.

4. Evaluate skin turgor, capillary refill, and mucous membranes. Indirect indicators of hydration.

5. Note nausea and fever. Both affect intake, fluid needs, and route of replacement.

6. Monitor platelets, Hb/Hct, and clotting studies. When the platelet count is less than 20,000/mm (from WBC proliferation or marrow suppression by antineoplastic drugs), the patient is prone to spontaneous life-threatening bleeding. Falling Hb/Hct indicates bleeding, which may be occult.

7. Promote good nutrition. Chemotherapy can cause weight loss and anorexia, so push high-calorie, high-protein foods. Chemotherapy with adjunctive prednisone can instead cause weight gain, so dietary counseling helps either way.

8. Encourage fluids up to 3-4 L/day once oral intake resumes. Promotes urine flow, prevents uric acid precipitation, and clears antineoplastic drugs.

9. Provide hydration, a high-residue diet, stool softeners, and mild laxatives. Encourage walking. Prevents constipation.

10. Encourage oral hygiene. Limit oral care to mouthwash if indicated, and avoid alcohol-based rinses. When bleeding is present, even gentle brushing can damage tissue, and alcohol dries and stings irritated tissue.

11. Provide a soft diet. Reduces gum irritation.

12. Administer IV fluids as indicated. Maintains fluid and electrolyte balance when oral intake fails, minimizes tumor lysis syndrome, and protects the kidneys.

13. Administer medications as indicated. See Pharmacologic Management.

14. Administer RBCs, platelets, and clotting factors. Restores RBC count and oxygen-carrying capacity to correct anemia, and prevents or treats hemorrhage.

15. Maintain the external central vascular access device (subclavian or tunneled catheter, or implanted port). Removes peripheral venipuncture as a bleeding source.

3. Managing Acute Pain

Pain in leukemia comes from bone and joint involvement, chemotherapy and radiation, and the anxiety that rides along with all of it.

1. Investigate reports of pain. Note changes in degree (use a 0-10 scale) and site. Guides intervention and may flag developing complications.

2. Monitor vital signs and nonverbal cues such as muscle tension and restlessness. Helps evaluate verbal reports and the effectiveness of interventions.

3. Monitor uric acid level as appropriate. Rapid destruction of leukemic cells during chemotherapy raises uric acid, causing swollen, painful joints. Massive WBC infiltration into joints also produces intense pain.

4. Provide a quiet environment. Limit noise, lighting, and interruptions. Promotes rest and supports coping.

5. Position for comfort and support joints and extremities with pillows or padding. Eases bone and joint discomfort.

6. Reposition periodically and assist with gentle ROM exercises. Improves tissue circulation and joint mobility.

7. Provide comfort measures (massage, heat or cool packs) and psychological support. Reduces the need for medication or boosts its effect.

8. Review the patient's own comfort measures. Patient involvement is what makes pain management work, and it builds a sense of control they can carry home.

9. Evaluate and support the patient's coping mechanisms. Learned techniques help patients manage pain more effectively.

10. Encourage diversion and relaxation: music, guided imagery, deep breathing, reading, TV, crafts, games, or time with family. Distraction and relaxation lower pain intensity.

11. Protect a quiet, restful environment. Good sleep hygiene and low stimulation keep pain from escalating.

12. Administer medications as indicated. See Pharmacologic Management.

4. Enhancing Activity Tolerance

Weakness, treatment restrictions, and anemia from marrow suppression leave these patients short on energy. Build tolerance gradually.

1. Evaluate fatigue and inability to participate in activities or ADLs. The effects of leukemia, anemia, and chemotherapy are cumulative, especially during active treatment.

2. Monitor vital signs and oxygen saturation. Reduced activity and anemia show up here first.

3. Assess for dyspnea or chest pain. Deconditioning causes dyspnea, while anemia or infection can produce chest pain.

4. Have the patient keep a diary of daily routines and energy levels, noting what worsens fatigue. Helps prioritize activity around the fatigue pattern.

5. Provide a quiet environment with uninterrupted rest periods, including rest before meals. Restores energy for activity and tissue healing.

6. Use energy-saving techniques (sitting rather than standing, pacing activity, shower chair). Assist with ambulation as needed. Maximizes available energy for self-care.

7. Schedule meals around chemotherapy. Give oral hygiene before meals and antiemetics as indicated. Reduces nausea and improves intake.

8. Recommend small, high-protein meals and snacks through the day. Smaller meals take less energy to digest while still fueling the body.

9. Encourage moderate exercise as tolerated: stretching, short walks, light aerobic work, light resistance bands, swimming, or yoga. Builds endurance, balance, and functional capacity.

10. Provide supplemental oxygen. Maximizes oxygen for cellular uptake and improves activity tolerance.

5. Health Teaching and Patient Education

Teach the specific type of leukemia, treatment options, side effects, and self-care. Patients need to know their medication schedule, the signs of infection or complications, and the value of followup and blood count monitoring.

1. Review the pathology of the specific leukemia and the treatment options. Treatment can include antineoplastic drugs, transfusions, peripheral stem cell transplant, or bone marrow transplant.

2. Build a trusting relationship and let the patient and family voice anger and depression. Include family in care. A cancer diagnosis is devastating, and giving people room to talk promotes understanding and cooperation.

3. Use visual aids (diagrams, illustrations, videos) when teaching. Improves understanding and retention.

4. Involve family and support persons in education. A family that understands the disease and self-care can provide better support.

5. Reinforce key concepts in both verbal and written form. Repetition across formats improves retention.

6. Refer to appropriate support groups and community resources. Connects the patient to added education and services.

6. Monitoring for Complications

Leukemia and its treatment generate complications fast. Your job is early detection of infection, bleeding, organ dysfunction, tumor lysis syndrome, febrile neutropenia, and sepsis.

1. Assess vital signs regularly. Temperature, HR, RR, and BP flag early infection or sepsis and systemic complications.

2. Monitor the complete blood count (CBC). WBC count, hemoglobin, and platelets reveal infection risk, anemia, and thrombocytopenia early.

3. Assess for signs of infection. Fever, chills, tachycardia, or mental status change call for prompt antimicrobial therapy.

4. Assess skin integrity. Compromised immunity raises the risk of skin infection and delayed healing, so catch breakdown early.

5. Assess neurologic status. Mental status, orientation, motor, and sensory checks catch CNS complications of the disease or its treatment.

6. Assess pain with an appropriate scale. Consistent assessment guides medication adjustments and points to underlying causes.

7. Monitor fluid balance. I&O, hydration status, electrolytes, and urine specific gravity prevent renal dysfunction and electrolyte imbalance.

8. Assess psychosocial well-being. Watch for distress, anxiety, and depression so you can intervene and support early.

7. Medications and Pharmacologic Support

Know each drug, its mechanism, its dose schedule, and its interactions, and watch closely for adverse reactions.

1. Chemotherapy agents. Methotrexate, cytarabine, vincristine, and daunorubicin kill leukemia cells or block their growth, given in combinations and schedules set by the type and stage.

2. Targeted therapy. Imatinib, dasatinib, and nilotinib inhibit specific proteins or genes driving certain leukemias (for example, chronic myeloid leukemia).

3. Immunotherapy. Monoclonal antibodies (rituximab, alemtuzumab) and immune checkpoint inhibitors (pembrolizumab, nivolumab) prime the immune system to destroy leukemia cells.

4. Hematopoietic stem cell transplant (HSCT) medications. High-dose conditioning chemotherapy plus immunosuppressants (cyclosporine, methotrexate) prevent graft-versus-host disease and promote engraftment.

5. Antifungal and antibacterial agents. Antifungals (fluconazole, voriconazole) and antibacterials (cefepime, meropenem) treat or prevent infection in an immunocompromised patient.

6. Colony-stimulating factors: sargramostim (Leukine). Restores WBCs destroyed by chemotherapy and cuts the risk of severe infection and death in certain leukemias.

7. Antiemetics: 5-HT3 receptor antagonists such as ondansetron (Zofran) or granisetron (Kytril). Relieve chemotherapy-induced nausea and vomiting.

8. Allopurinol (Zyloprim). Improves renal excretion of toxic breakdown products and reduces uric acid nephropathy.

9. Potassium acetate or citrate, sodium bicarbonate. Alkalinize the urine to prevent tumor lysis syndrome and kidney stones.

10. Stool softeners. Reduce straining and trauma to rectal tissue.

11. Oral contraceptives. Minimize blood loss by slowing or stopping menstrual flow.

12. Analgesics: acetaminophen (Tylenol). For mild pain not relieved by comfort measures. Avoid aspirin-containing products, which can potentiate hemorrhage.

13. Opioids: codeine, morphine, hydromorphone (Dilaudid). Used around-the-clock, not PRN, when pain is severe. Patient-controlled analgesia (PCA) avoids the peaks and valleys of intermittent dosing and gives the patient control.

14. Antianxiety agents: diazepam (Valium), lorazepam (Ativan). Enhance the action of analgesics and opioids.

8. Laboratory and Diagnostic Procedures

1. CBC, noting a falling WBC count or sudden changes in neutrophils. Fewer normal WBCs from disease or chemotherapy compromise immunity and raise infection risk.

2. Peripheral blood smear. Microscopic look at cell shape and size to spot abnormal morphology and leukemia cells.

3. Bone marrow aspiration and biopsy. Determines the leukemia type, the percentage of leukemic cells, and the response to treatment.

4. Gram stain, cultures, and sensitivity. Confirms infection, identifies the organism, and directs therapy.

5. Flow cytometry. Uses fluorescent-labeled antibodies to identify and classify cell populations, including leukemia cells.

6. Cytogenetic analysis. Examines chromosomes for abnormalities or mutations that guide diagnosis, prognosis, and treatment.

7. Molecular testing. PCR and FISH detect genetic alterations tied to specific leukemias and track minimal residual disease.

8. Imaging studies. X-ray, CT, MRI, or PET assess disease extent, lymph node enlargement, organ complications, and treatment response.

9. Lumbar puncture (spinal tap). Samples cerebrospinal fluid to detect leukemia cells or CNS involvement.

10. Blood chemistry panels. Electrolytes, liver and kidney function, and coagulation profile assess organ function and treatment-related toxicity.